Метою дослідження є ідентифікація та кількісне визначення празозину гідрохлориду за уніфікованою ВЕРХ-методикою, що базується на застосуванні: обернено-фазного варіанту хроматографування, лінійного градієнту та багатоканального УФ-детектування речовин, яке дозволяє отримувати надійні результати досліджень лікарських речовин та їх сумішей у біологічних об'єктах. Матеріали та методи. ВЕРХ-хроматографування проводили на мікроколоночному рідинному хроматографі «Міліхром А-02» ("ЕкоНова" Новосибірськ, Росія) в обернено-фазному варіанті. У дослідженні застосовували реактиви кваліфікації «для ВЕРХ» та «ЧДА». Празозину гідрохлорид виділяли з таблеток «Празозин-Ратіофарм» (50 шт.) по 1 мг (Меркле ГмбХ, Німеччина). Чистоту субстанції перевірено методами тонкошарової хроматографії (ТШХ) та УФ-спектроскопії і встановлено відповідність якості щодо вимог Державної Фармакопеї України (ДФУ). Результати дослідження. При проведенні ідентифікації встановлено абсолютні часи утримування (15,99-16,12 хв.) та об´єми утримування (1598,5-1611,5 мкл) празозину гідрохлориду, спектральні відношення, межу виявлення препарату у пробі (8,0 мкг/мл або 32,0 нг у пробі), значення коефіцієнтів симетрії піків речовини (0,96-1,04) та коефіцієнтів ємності (9, 96). Методом найменших квадратів розраховано коефіцієнти регресії градуювального графіку, якому відповідало рівняння прямої S=0,00134 С. Коефіцієнт кореляції дорівнював 0,9993. Розраховано валідаційні характеристики ВЕРХ-методики визначення празозину гідрохлориду: діапазон лінійності (10,0-200,0 мкг/мл), межу кількісного визначення (10,0 мкг/мл або 40 нг у пробі), правильність та точність за результатами кількісного визначення препарату ВЕРХ-методом у модельних розчинах (RSD x =67, 9 %) .
Introduction
Prazosin hydrochloride, like other quinazoline derivatives (doxazosin, alfuzosin and terazosin), belongs to the group of α 1 -adrenoblockers and is used in medical practice for the treatment of arterial hypertension and prostatic hypertrophy [1, 2] . The drug is used for the effective treatment of post-traumatic stress disorder in children and servicemen who work in difficult conditions [3, 4] .
For the last 5 years, scientists have focused on the use of prazosin in the treatment posttraumatic stress disorder and alcohol dependence, which is due to the increased probability of suicide attempts in patients, exacerbation of mental disorders. It was found that prazosin improved the results of treatment for alcohol abuse among individuals with posttraumatic stress disorder at different dosing regimens, blocked the stressinduced increase in anxiety that occurs during deprivation of alcohol [5, 6] .
Existing pharmacological treatment options for nightmares in military veterans associated with hostilities are not effective. As a result of the low profile of side effects and the ability to improve sleep and reduce the nightmares after trauma prazosin has been recommended as an adjuvant therapy [7, 8] .
According to the literature data for the period from 2014 to 2017 years in the experiments on animal, scientists were found actual directions of the therapeutic use of prazosin. Development of glioblastomaan ag-gressive form of primary brain tumor was inhibited when using prazosin [9] . Alpha-adrenergic blockers (prazosin, doxazosin, and terazosin) demonstrated a hepatoprotective effect in the inhibition of elevated catecholamine, which is used in the treatment of acute hepatic insufficiency associated with paracetamol toxicity [10] .
To monitor alpha-adrenergic blockers, highly sensitive analytical methods were developed. Quantitative determination of doxazosin mesylate in pharmaceutical preparations and human plasma was carried out using the spectrofluorometric method [11] . Determination of doxazosin and alfuzosin in pharmaceutical preparations, urine samples and plasma samples were carried out according to the procedure of mixed micellar extraction combined with magnetic dispersive μ-solid phase extraction [12] . An analytical method was developed for the study of 11 pharmaceutical preparations (caffeine, prazosin, enalapril, carbamazepine, nifedipine, levonorgestrel, simvastatin, hydrochlorothiazide, gliclazide, diclofenac-Na and mefenamic acid). The method included the steps of: isolation and concentration using solid phase extraction (Oasis HLB), a separation step using high performance liquid chromatography, and a time-of-flight mass spectrometry. The method was used for drinking water, surface water, wastewater treatment plants and wastewater [13] .
When applying prazosin, there are possible side effects: headache, weakness, dizziness, insomnia, due to active lowering of blood pressure. Destruction of the functions of the digestive tract is manifested by nausea, dry mouth, oral allergic reactions, peripheral edema [1] . In case of overdose or self-medicate with prazosin the cardiovascular system is affected, the activity of the central nervous system is suppressed, respiratory system is broken [14, 15] .
Formulation of the problem in general view, relevance of the topic and its relevance to important scientific or practical issues
The previously developed methods of HPLC analysis of prazosin hydrochloride are distinguished by the use of different chromatographic conditions, which are based on the individual properties of investigated substance. Given that, with insufficient or slow development of the antihypertensive effect, prazosin is combined with diuretics, β-adrenoblockers, clonidine, or other antihypertensive agents [1, 2] , an important stage for the further research of medicinal substances and their mixtures in biological objects is the development of a unified HPLC method and the creation of databases by the parameters of identification and quantitative determination of analytes. The results of research on a unified HPLC method can be recommended for the introduction into the practice of the bureau of forensic examination, toxicological centers, clinical laboratories regarding the study of medicinal substances in biological objects.
Analysis of recent studies and publications in which a solution of the problem and which draws on the author
Methods of identification and quantification of prazosin hydrochloride by HPLC method in the application of various detection options (UV spectrophotometric [16] , mass spectrometry [17, 18] , photodiode [18] ) were described in the literature.
Analysis of prazosin in various matrices was carried out using different sorbents, composition of moving phases, buffer solutions in isocratic and gradient elution modes.
The detection of the prazosin hydrochloride by the UV spectrophotometric detector at one or two wavelengths limited the use of HPLC-method for the analysis of drug mixtures in biological objects.
Results of the HPLC-study of alpha-adrenergicblocker drug substances in the presence of degradation products were obtained by the use of water-acetonitrilemethanol-glacial acetic acid-diethylamine (25: 35: 40: 1: 0,017) as mobile phase for prazosin and terazosin and acetonitrile-water-glacial acetic acid-diethylamine (65: 35: 1: 0,02) for doxazosin in isocratic mode. The detection was performed at 254 nm [16] .
For quantification of prazosin in plasma, urine and whole blood by HPLC method chromatographic conditions were used: column with a nonpolar sorbent Nuclosil 100-10C 18, 10 μm; the investigated substance was eluted in isocratic mode; the mobile phase-methanolwater-acetonitrile (60: 45: 5, pH 3,83). The detection was performed at 240 nm [18] .
Identification and quantification of prazosin hydrochloride by HPLC method in the Pharmaceutical formulations were carried out in the following chromato-graphic conditions: column with a nonpolar sorbent Thermo Scientific C18, 5 μm; the prazosin was eluted in gradient mode: the mobile phase -(A) 0,1 % formic acid in methanol-water (10:90) and (B) acetonitrile-methanol (3: 1). Elution began with 5 % B and then linearly increased to 60 % B for 3 minutes, additionally increased to 97 % B for 3 minutes, and then remained isocratic for 5 minutes [18] .
Allocation of unsolved parts of the general problem, which is dedicated to the article
The aim of research is the identification and quantification of prazosin hydrochloride according to the unified HPLC method, that based on application:
reverse-phase chromatography, which is characterized by a high speed of the establishment of sorption equilibrium, the ease and completeness of the desorption of components from a nonpolar sorbent in small volumes of solvent;
linear gradient at elution of investigated substances, which creates conditions for the exit from the column of all components of the sample in the form of narrow zones;
multichannel ultraviolet detection of substances that allows you to obtain reliable results for all investigated analytes [19] .
Formulation of the aim (tasks) of article
In order to achieve this purpose, it was necessary to solve the following tasks:
1. To determine the main parameters of retention of prazosin hydrochloride, spectral ratios, and the detection limit of the drug in the sample.
2. To work out the HPLC-method of quantitative determination of prazosin hydrochloride on model solutions using different concentrations of the preparation.
3. To calculate validation characteristics of HPLC-method for determination of prazosin hydrochloride: range of linearity, limit of quantitative determination, correctness and accuracy based on the results of the quantitative determination of the preparation by the HPLC method in model solutions.
Statement of the basic material of the study (methods and objects) with the justification of the results

Materials and methods
Prazosin hydrochloride was isolated from tablets Prazosin-Ratiofarm (50 pcs.) of 1 mg (Merkel GmbH & Co., Germany) as follows: 50 tablets were transferred to a porcelain mortar and triturated to a homogeneous state, then 50 ml of methanol were added and mixed thoroughly. The resulting mixture was filtered through a paper filter in a porcelain cup and evaporated in a water bath at a temperature of not more than 40 °C to remove the organic solvent; the residue was dried. The purity of the substance was checked by TLC and UV spectroscopy and the quality complies with the requirements of the SPhU.
Reagents for the HPLC-method test corresponded to the "HPLC" qualification: acetonitrile (Sigma-Aldrich Laborchemikallen, GmbH), methanol (Merk, Darmstadt, Germany), water poorly distilled (Merk, Darmstadt, Germany). Reagents corresponded qualification "PFA": lithium perchlorate trihydrate (Sigma-Aldrich, USA) perchloric acid (70 %) (Chimmed, Moscow, Russia).
Method of research by the HPLC method
HPLC chromatography was performed on a microcolonial liquid chromatograph "Milichrome A-02" ("EcoNova", Novosibirsk, Russia) in an reverse-phase variant using a metal column with a nonpolar sorbent Prontosil 120-5C 18 AQ, 5 μm. The investigated sub stances were eluted in linear gradient mode: from eluent А (5 % acetonitrile and 95 % buffer solution -0.2 М solution of lithium perchlorate in 0.005 М solution perchloric acid) to eluent B (100 % acetonitrile) as during 40 min.
Regeneration of column has been conducted during 2 min with mixture of solvents; the flow rate of the mobile phase has been formed 100 μl/min, column temperature -40 С; pump pressure -6.0 MPa; injection volume -4 μl [19, 20] (Fig. 1) . Fig. 1 . Chromatogram of prazosin hydrochloride (concentration -50.0 μg / ml) Detection was performed using a two-beam multiwave UV spectrophotometer with 8 wavelengths: 210, 220, 230, 240, 250, 260, 280 and 300 nm, for each value of the wavelength on the substance chromatogram, a corresponding peak with the same retention time was observed, but with different amplitudes, directly proportional to the extinction of the substance.
Method of identification of prazosin hydrochloride by HPLC method
0.025 g of the investigated substance was placed in a volumetric flask of 500.0 ml, dissolved in 5 % solvent acetonitrile and 95 % buffer solution. The volume of the solution was brought to the mark with a solvent (standard solution at a concentration of 50.0 μg / ml). In a series of volumetric flasks of 100.0 ml were introduced from the burette 20.0; 40.0; 60.0 and 80.0 ml of standard solution and volume of solutions was added to the mark with the appropriate solvent (solutions 1-4 had a concentration of 10.0-40.0 μg / ml respectively). In chromatography, using a unified HPLC method, solutions of prazosin hydrochloride (at least 5 chromatograms for each study) were obtained symmetric, sharp in the shape of the peak, which allowed to calculate the results using the computer program "MultiChrom" ("Ampersend", Moscow, Russia), which was part of the chromatograph.
Method of quantitative determination of prazosin hydrochloride by the method of absolute calibration
0.10 g of prazosin hydrochloride was introduced into a volumetric flask of 500.0 ml, was dissolved in 5 % acetonitrile and 95 % buffer solution in a solvent, and the volume of the solution was adjusted to the mark by the appropriate solvent (standard solution, concentration 200.0 μg / ml).
In a series of volumetric flasks of 100.0 ml were introduced from the burette 5.0; 12.5; 25.0; 37.5; 50.0; 62.5; 75.0 and 87.5 ml of standard solution and volume of solutions was added to the mark with the appropriate solvent (working standard solutions 1 to 8 with concentrations of 10.0; 25.0; 50.0; 75.0; 100.0; 125.0; 150.0 and 175.0 μg / ml, respectively). The results of the HPLC analysis were used to construct the calibration graph in coordinates: S, mm 2 (peak area) -C, μg / ml (concentration of solutions of the investigated substance).
Research results and their discussion
The identification of prazosin hydrochloride conducted with using absolute parameters of retention time (t R ) and retention volume (V R ) ( Table 1 ). Spectral relationships are determined for reliable identification of substance at values of wavelengthfrom 220 to 300 nm (S 220-300 /S 210 ), which were equal: 0.792, 0.916, 1.723, 2.025, 1.508, 0.476, 0.305.
The suitability of the chromatographic system for HPLC studies of prazosin hydrochloride was con-firmed in determining the coefficients of the symmetry of the peaks of the substance (Ks) (not exceeding the optimal values of 2.0-2.5) And coefficients of capacity ratio (k') (were not less than values of 0.5-2.0). It has been found that the limit of detection of prazosin hydrochloride by the HPLC method is 8.0 μg / ml or 32.0 ng in the sample. In the quantitative determination of prazosin hydrochloride, the linearity of the calibration graph in coordinates (S, mm 2 ) -(C, μg / ml) was observed in the range of concentrations 10.0-200.0 μg / ml, which corresponds to the content of prazosin hydrochloride in the sample from 40.0 ng to 800.0 ng, respectively. The lower limit of determination of prazosin hydrochloride by the HPLC method was 10.0 μg / ml, which corresponds to 40.0 ng in the sample (Fig. 2) .
Regression coefficients of the calibration graph S=вC+a is calculated using the least squares method ( Table 2 ). The equation of the line S=0.00134 С -0.000238 corresponds to the indicated calibration graph. As a result of checking the significance of a free member of the graduation graph equation, it was found that it was slightly different from zero; therefore, an equation of form was used to determine the content of a substance in research objects S=0.000134 С; the correlation coefficient (R) was equal to 0.9993.
The relative uncertainty of the average result did not exceed +1.89 % when HPLC analysing of prazosin hydrochloride in model solutions using the proposed method (Table 3) . The method of HPLC analysis of prazosin hydrochloride is validated by parametersthe range of linearity, the limits of detection and quantification, rightness and accuracy which based on the results of quantitative determination of prazosin hydrochloride by HPLC method in model solutions (RSD x =67.9 %).
Conclusions
1. Identification and quantification of prazosin using a unified HPLC method suitable for the study of medicinal substances and their mixtures in biological objects were carried out.
2. Validation characteristics of HPLC-method for determination of prazosin hydrochloride: range of linearity (10.0-200.0 µg / ml), limit of quantitative determination (10.0 µg / ml or 40 ng of sample), correctness and accuracy, which based on the results of the quantitative determination of the preparation by the HPLC method in model solutions (RSD x =67.9 %) were calculated.
